Cidara Therapeutics Inc
NASDAQ:CDTX
Income Statement
Earnings Waterfall
Cidara Therapeutics Inc
Revenue
|
63.9m
USD
|
Cost of Revenue
|
-1.5m
USD
|
Gross Profit
|
62.4m
USD
|
Operating Expenses
|
-86.9m
USD
|
Operating Income
|
-24.5m
USD
|
Other Expenses
|
1.6m
USD
|
Net Income
|
-22.9m
USD
|
Income Statement
Cidara Therapeutics Inc
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
19
N/A
|
21
+10%
|
23
+12%
|
27
+14%
|
10
-62%
|
12
+19%
|
12
-1%
|
41
+247%
|
46
+11%
|
50
+8%
|
54
+10%
|
28
-49%
|
61
+122%
|
64
+5%
|
83
+29%
|
85
+2%
|
57
-33%
|
64
+13%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
|
Gross Profit |
(2)
N/A
|
(2)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
12
N/A
|
62
+406%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(6)
|
(10)
|
(18)
|
(21)
|
(27)
|
(32)
|
(35)
|
(41)
|
(44)
|
(48)
|
(52)
|
(57)
|
(57)
|
(56)
|
(59)
|
(58)
|
(60)
|
(63)
|
(63)
|
(62)
|
(63)
|
(63)
|
(63)
|
(71)
|
(75)
|
(84)
|
(87)
|
(88)
|
(93)
|
(92)
|
(97)
|
(94)
|
(95)
|
(94)
|
(92)
|
(93)
|
(88)
|
(87)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(16)
|
(16)
|
(17)
|
(17)
|
(18)
|
(19)
|
(19)
|
(19)
|
(20)
|
(18)
|
(18)
|
(17)
|
(15)
|
(18)
|
|
Research & Development |
(3)
|
(7)
|
(11)
|
(15)
|
(19)
|
(23)
|
(26)
|
(30)
|
(32)
|
(36)
|
(39)
|
(43)
|
(44)
|
(43)
|
(46)
|
(44)
|
(46)
|
(49)
|
(49)
|
(48)
|
(48)
|
(46)
|
(47)
|
(54)
|
(58)
|
(68)
|
(71)
|
(71)
|
(75)
|
(73)
|
(77)
|
(75)
|
(74)
|
(76)
|
(74)
|
(76)
|
(73)
|
(69)
|
|
Operating Income |
(7)
N/A
|
(12)
-60%
|
(18)
-53%
|
(21)
-19%
|
(27)
-28%
|
(32)
-19%
|
(35)
-10%
|
(41)
-15%
|
(44)
-8%
|
(48)
-10%
|
(52)
-7%
|
(57)
-9%
|
(57)
+0%
|
(56)
+2%
|
(59)
-6%
|
(58)
+2%
|
(60)
-4%
|
(63)
-5%
|
(63)
+1%
|
(62)
+1%
|
(44)
+29%
|
(42)
+6%
|
(40)
+4%
|
(44)
-10%
|
(64)
-47%
|
(72)
-12%
|
(76)
-5%
|
(47)
+38%
|
(47)
-1%
|
(42)
+10%
|
(42)
0%
|
(66)
-56%
|
(33)
+50%
|
(30)
+11%
|
(8)
+71%
|
(8)
+3%
|
(32)
-286%
|
(24)
+23%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(1)
|
0
|
4
|
4
|
6
|
5
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
2
|
2
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(8)
N/A
|
(12)
-55%
|
(18)
-51%
|
(21)
-18%
|
(27)
-28%
|
(32)
-19%
|
(35)
-9%
|
(41)
-15%
|
(44)
-8%
|
(48)
-10%
|
(52)
-7%
|
(57)
-9%
|
(57)
0%
|
(56)
+2%
|
(59)
-6%
|
(59)
+1%
|
(60)
-2%
|
(59)
+2%
|
(59)
+0%
|
(56)
+5%
|
(39)
+30%
|
(41)
-4%
|
(39)
+5%
|
(44)
-12%
|
(65)
-47%
|
(72)
-12%
|
(76)
-5%
|
(47)
+38%
|
(47)
-1%
|
(42)
+10%
|
(42)
+0%
|
(66)
-56%
|
(33)
+50%
|
(30)
+11%
|
(8)
+73%
|
(7)
+11%
|
(30)
-321%
|
(22)
+25%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
|
Income from Continuing Operations |
(8)
|
(12)
|
(18)
|
(21)
|
(27)
|
(32)
|
(35)
|
(41)
|
(44)
|
(48)
|
(52)
|
(57)
|
(57)
|
(56)
|
(59)
|
(59)
|
(60)
|
(59)
|
(59)
|
(56)
|
(39)
|
(41)
|
(39)
|
(44)
|
(65)
|
(72)
|
(76)
|
(47)
|
(47)
|
(42)
|
(42)
|
(66)
|
(33)
|
(30)
|
(8)
|
(8)
|
(31)
|
(23)
|
|
Net Income (Common) |
(8)
N/A
|
(12)
-55%
|
(18)
-51%
|
(21)
-18%
|
(27)
-28%
|
(32)
-19%
|
(35)
-9%
|
(41)
-15%
|
(44)
-8%
|
(48)
-10%
|
(52)
-7%
|
(57)
-9%
|
(57)
0%
|
(56)
+2%
|
(59)
-6%
|
(69)
-17%
|
(70)
-2%
|
(69)
+2%
|
(69)
+0%
|
(56)
+20%
|
(39)
+29%
|
(41)
-4%
|
(42)
-2%
|
(47)
-12%
|
(67)
-43%
|
(75)
-11%
|
(74)
+1%
|
(47)
+37%
|
(47)
-1%
|
(42)
+10%
|
(44)
-4%
|
(63)
-43%
|
(33)
+47%
|
(30)
+10%
|
(9)
+70%
|
(11)
-26%
|
(31)
-177%
|
(23)
+27%
|
|
EPS (Diluted) |
-0.57
N/A
|
-0.88
-54%
|
-1.33
-51%
|
-1.56
-17%
|
-1.98
-27%
|
-2.34
-18%
|
-2.55
-9%
|
-2.93
-15%
|
-3.14
-7%
|
-3.32
-6%
|
-3.08
+7%
|
-3.36
-9%
|
-3.36
N/A
|
-3.18
+5%
|
-2.82
+11%
|
-2.92
-4%
|
-2.54
+13%
|
-2.76
-9%
|
-2.49
+10%
|
-1.81
+27%
|
-1.01
+44%
|
-1.41
-40%
|
-1.1
+22%
|
-1.14
-4%
|
-1.55
-36%
|
-1.8
-16%
|
-1.53
+15%
|
-0.78
+49%
|
-0.95
-22%
|
-0.81
+15%
|
-0.65
+20%
|
-0.87
-34%
|
-0.37
+57%
|
-0.43
-16%
|
-0.08
+81%
|
-0.12
-50%
|
-0.34
-183%
|
-0.26
+24%
|